Jefferies analyst Keith Devas lowered the firm’s price target on Perrigo (PRGO) to $23 from $27 and keeps a Hold rating on the shares. Macro headwinds continue to be felt more acutely in consumer health than other pockets of staples, says the analyst, who lowered targets and estimates across the firm’s consumer health coverage into Q3 earnings reports from the group.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
